WithdrawnNCT00470639
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand what a digital app or remote support tool can reveal about signals in the brain or body that may guide care later on.
DepressionOtherFrom 18 Years to 80 Years
- Countries
- Australia
- Sponsor
- The University of New South Wales
- Condition
- Depression
CompletedNCT03266679
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
BipolarityOther
- Countries
- Australia
- Sponsor
- Queensland University of Technology
- Condition
- Bipolarity
CompletedNCT00483548
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
DepressionOtherOver 18 Years
- Countries
- Australia, India, United States
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Condition
- Depression
CompletedNCT03197974
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- Australia
- Sponsor
- Swinburne University of Technology
- Condition
- Bipolarity
CompletedNCT00436020
This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
DepressionOtherFrom 18 Years to 70 Years
- Countries
- Australia
- Sponsor
- Bayside Health
- Condition
- Depression
TerminatedNCT01121536
This study exists to better understand the safety of a therapy or guided support program and how manageable it feels in practice. Researchers are trying to understand how people respond to a therapy or guided support program in practice and what may need to be adjusted.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- Argentina, Australia, Brazil, Bulgaria, Canada, Croatia, France, Germany, Hungary, Italy, Poland, Serbia, Slovakia, South Africa, Spain, Ukraine, United States
- Sponsor
- Cephalon
- Condition
- Depression
CompletedNCT00202293
This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can work better when mental health difficulties overlap with substance use.
SchizophreniaOtherFrom 15 Years to 29 Years
- Countries
- Australia
- Sponsor
- Melbourne Health
- Condition
- Schizophrenia
CompletedNCT01890356
This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can better prevent setbacks and support longer-term stability.
DepressionOtherOver 18 Years
- Countries
- Australia
- Sponsor
- The University of New South Wales
- Condition
- Depression
CompletedNCT02118623
This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can make support easier to access outside standard clinic visits.
BipolarityOtherFrom 21 Years to 65 Years
- Countries
- Australia
- Sponsor
- University of Melbourne
- Condition
- Bipolarity
CompletedNCT00360126
This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
BipolarityOtherOver 18 Years
- Countries
- Australia
- Sponsor
- GlaxoSmithKline
- Condition
- Bipolarity
CompletedNCT01358357
This study exists to understand how the medication Lurasidone holds up over time after the earliest research stage. Researchers are trying to understand how people respond to the medication Lurasidone in practice and what may need to be adjusted.
BipolarityOtherOver 18 Years
- Countries
- Argentina, Australia, Bulgaria, Chile, Croatia, Czech Republic, France, Hungary, Japan, Poland, Russian Federation, Serbia, Slovakia, United States
- Sponsor
- Sumitomo Pharma America, Inc.
- Condition
- Bipolarity
CompletedNCT01072630
This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.
DepressionOtherFrom 18 Years to 65 Years
- Countries
- Argentina, Australia, Bulgaria, Canada, France, Poland, South Africa, Spain, Ukraine, United States
- Sponsor
- Cephalon
- Condition
- Depression
CompletedNCT01562184
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
DepressionOtherOver 18 Years
- Countries
- Australia, United States
- Sponsor
- The University of New South Wales
- Condition
- Depression
CompletedNCT01339598
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
BipolarityOtherFrom 18 Years to 65 Years
- Countries
- Australia
- Sponsor
- The University of New South Wales
- Condition
- Bipolarity
CompletedNCT01076361
This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
BipolarityOther
- Countries
- Australia, Austria, Belgium, Canada, Denmark, France, Germany, Italy, Netherlands, Serbia and Montenegro, Spain, Sweden, Switzerland, United States
- Sponsor
- Medtronic
- Condition
- Bipolarity
CompletedNCT05402657
This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
DepressionOtherOver 18 Years
- Countries
- Australia, United States
- Sponsor
- The George Institute
- Condition
- Depression
CompletedNCT06003309
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
DepressionOtherFrom 18 Years to 80 Years
- Countries
- Australia, United States
- Sponsor
- University of California, San Diego
- Condition
- Depression
RecruitingNCT07315516
This study exists to compare options and see whether blood tests and biological markers offers something meaningfully different. Researchers are trying to understand whether blood tests and biological markers can improve sleep, daily rhythms, and longer-term stability.
AnxietyOtherOver 18 Years
- Countries
- Australia
- Sponsor
- RDC Clinical Pty Ltd
- Condition
- Anxiety
Active Not RecruitingNCT05528302
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
AnxietyOtherOver 18 Years
- Countries
- Australia
- Sponsor
- The University of Queensland
- Condition
- Anxiety
CompletedNCT06593847
This study exists to understand what helps a therapy or guided support program work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.
AnxietyOtherFrom 18 Years to 70 Years
- Countries
- Australia, China, Germany, Netherlands, United States
- Sponsor
- Boston University Charles River Campus
- Condition
- Anxiety
RecruitingNCT06483789
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand how people respond to a digital app or remote support tool in practice and what may need to be adjusted.
AnxietyOtherFrom 18 Years to 65 Years
- Countries
- Australia
- Sponsor
- HB BioTech, LLC
- Condition
- Anxiety
RecruitingNCT06947941
This study exists to explore whether this type of care could improve care and understanding. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
SchizophreniaOtherFrom 55 Years to 90 Years
- Countries
- Australia, Canada, Japan, United Kingdom, United States
- Sponsor
- Bristol-Myers Squibb
- Condition
- Schizophrenia
TerminatedNCT05211947
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand what a medication treatment could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 51 Years
- Countries
- Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Italy, Japan, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, Philippines, Poland, Portugal, Romania, Serbia, Slovakia, South Korea, Spain, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, United States
- Sponsor
- Boehringer Ingelheim
- Condition
- Schizophrenia
CompletedNCT04846868
This study exists to learn from real-world information that can show how the medication Iclepertin fits into care. Researchers are trying to understand whether the medication Iclepertin can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- Australia, Brazil, Canada, China, Colombia, Germany, Greece, Italy, Japan, Mexico, New Zealand, Norway, Philippines, Poland, Sweden, Turkey, United States
- Sponsor
- Boehringer Ingelheim
- Condition
- Schizophrenia
CompletedNCT02751632
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, can play a useful role in care. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 12 Years to 25 Years
- Countries
- Australia
- Sponsor
- Orygen
- Condition
- Schizophrenia